Drug intelligence / Profile preview

5'-S-[2-(decylamino)ethyl]-5'-thioadenosine

Development stage: Unknown
Modality: Small Molecules

Overview

5'-S-[2-(decylamino)ethyl]-5'-thioadenosine is a synthetic small molecule belonging to the class of 5'-deoxy-5'-thionucleosides, specifically a thio-substituted adenosine derivative where the 5' position is modified with a (decylamino)ethyl group via a sulfur atom. Its chemical formula is C22H38N6O3S and it has an average molecular weight of approximately 466.64 g/mol[1][2][3]. The compound is considered experimental and there are no approved indications or clinical trials reported for this molecule as of now[2]. No detailed mechanism of action, pharmacological activity, or therapeutic indication has been described in available sources.

Other names: 5'-S-[2-(decylamino)ethyl]-5'-thioadenosineS-[2-(Decylamino)ethyl]-5′-thioadenosine

Beyond the preview

Go deeper on 5'-S-[2-(decylamino)ethyl]-5'-thioadenosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-S-[2-(decylamino)ethyl]-5'-thioadenosine.

Explore the full profile